We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synthon’s Anti-HER2 ADC Frontrunner SYD985 Outperforms HER2-targeting ADC

News   Apr 03, 2014

 
Synthon’s Anti-HER2 ADC Frontrunner SYD985 Outperforms HER2-targeting ADC
 
 
 

RELATED ARTICLES

Chemical Reaction Method Makes Drug Production More Efficient

News

Researchers have created a more efficient method to produce the building blocks needed for cancer treatment drugs and antibiotics.

READ MORE

New Insights Into Cancer Progression Uncovered

News

Researchers discover a new circular ribonucleic acid (RNA) that increases tumor activity in soft tissue and connective tissue tumors.

READ MORE

Breakthrough in Preventing Chemotherapy-induced Hair Loss

News

Scientists have uncovered a novel method that could potentially prevent chemotherapy-induced hair loss.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE